Gene Therapy for Hemophilia B: A Transformative Breakthrough
Gene therapy for hemophilia B represents a groundbreaking advancement in hemophilia treatment that could reshape the lives of those affected by this disorder.Utilizing revolutionary techniques, such as Hemgenix, this innovative therapy offers the potential to correct the genetic abnormalities responsible for hemophilia, reducing the dependency on traditional clotting factor therapy.